# The Wells Investment

> The Wells Investment is a VC fund backing Artificial Intelligence and Health Care. See 10 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 10
- Last investment: May 2023
- Lead investor: 10%
- Last updated: Aug 2026

The Wells Investment is a VC fund focused on Artificial Intelligence and Health Care. The Wells Investment

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $2.2M–$12M |
| Series B | $10M–$17M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Artificial Intelligence | 3 | 30% |
| Health Care | 2 | 20% |
| Biotechnology | 2 | 20% |
| Apps | 1 | 10% |
| FinTech | 1 | 10% |

22 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 6 | 60% |
| Series B | 3 | 30% |
| Series C | 1 | 10% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Oasis Business | Oasis Business is an information services company that provides AI solutions to the finance, construction, and distribution industries. | $3.8M | Series A | May 24, 2023 |  |
| ADDD | Addd's AI technology analyses outdoor video data to determine the gender and age of the area's floating population. Furthermore, the effect can be measured and quantified by establishing whether they were aware of the advertisement and whether they viewed it with interest. This technology is also applicable to moving media and can be usedto determine the properties of moving things. It analyses video in real-time via the vision sensor camera and sends data solely to the client via a specified IP address to ensure privacy and safety. |  | Series A | May 05, 2023 |  |
| GenKOre | GenKOre operates as a biotech company, specializing in genetic scissors. | $12.3M | Series A | Nov 07, 2022 |  |
| Deargen | Deargen provides AI-based genome analysis service. | $16.6M | Series B | Feb 24, 2022 |  |
| Sendy | sendy Korea is a cloud-based logistics platform that provides on-demand freight transportation services. | $3.9M | Series A | Nov 23, 2021 |  |
| CodeBrick | Codebrick is a technical co-founder for local SEA entrepreneurs. Codebrick is a technical co-founder for local SEA entrepreneurs. Codebrick operates as an equity partner -this aligns the interests of the technical co-founder with those of the entrepreneur. | $12M | Series B | Jun 28, 2021 |  |
| 3billion | 3billion was founded with the goal of ending the diagnostic odyssey of rare disease patients through comprehensive genetic testing. It has reduced the amount of time and cost that was previously required for genome interpretation by using bioinformatics and machine learning technology, making genome-scale rare disease genetic testing affordable forpatients in need.The company was established in 2016 and is headquartered in Seoul, South Korea. | $13M | Series C | Mar 26, 2021 |  |
| 3billion | 3billion was founded with the goal of ending the diagnostic odyssey of rare disease patients through comprehensive genetic testing. It has reduced the amount of time and cost that was previously required for genome interpretation by using bioinformatics and machine learning technology, making genome-scale rare disease genetic testing affordable forpatients in need.The company was established in 2016 and is headquartered in Seoul, South Korea. | $10M | Series B | Oct 04, 2019 |  |
| 3billion | 3billion was founded with the goal of ending the diagnostic odyssey of rare disease patients through comprehensive genetic testing. It has reduced the amount of time and cost that was previously required for genome interpretation by using bioinformatics and machine learning technology, making genome-scale rare disease genetic testing affordable forpatients in need.The company was established in 2016 and is headquartered in Seoul, South Korea. | $2.2M | Series A | Jul 11, 2018 |  |
| MOIN | MOIN is a specialized cross-border payment network provider that offers remittance and payment services to both individuals and corporates | $2.3M | Series A | Jan 02, 2018 |  |

10 of 10 investments shown.

## Co-investors
- [The Wells Investment](https://shizune.co/investors/profile/the-wells-investment-849e) — VC Fund, 7 deals together
- [Korea Development Bank](https://shizune.co/investors/profile/korean-development-bank) — VC Fund, 3 deals together
- [JW Asset](https://shizune.co/investors/profile/jw-asset) — VC Fund, 2 deals together
- [Aju IB Investment](https://shizune.co/investors/profile/aju-ib-investment) — VC Fund, 1 deal together
- [Altos Ventures](https://shizune.co/investors/profile/altos-ventures) — VC Fund, 1 deal together
- [AVentures Capital](https://shizune.co/investors/profile/aventures-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Health Care Investors in South Korea](https://shizune.co/investors/health-care-investors-south-korea)
- [Health Care VC Funds in South Korea](https://shizune.co/investors/health-care-vc-funds-south-korea)
- [Biotech Investors in South Korea](https://shizune.co/investors/biotech-investors-south-korea)
- [Biotech VC Funds in South Korea](https://shizune.co/investors/biotech-vc-funds-south-korea)
- [Biotechnology Investors in South Korea](https://shizune.co/investors/biotechnology-investors-south-korea)
- [Biotechnology VC Funds in South Korea](https://shizune.co/investors/biotechnology-vc-funds-south-korea)

## FAQ

### What does The Wells Investment invest in?

The Wells Investment invests primarily in Artificial Intelligence, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 10 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is The Wells Investment's check size?

The Wells Investment typically joins rounds of $2.2M–$12M at Series A and $10M–$17M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds The Wells Investment participates in.

### When did The Wells Investment last invest?

The most recent investment recorded for The Wells Investment closed in May 2023. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co